US Patent Issued to Yale University on Oct. 27 for "Blockade of miR4661-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease" (Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,422, issued on Oct. 27, was assigned to Yale University (New Haven, Conn.).

"Blockade of miR4661-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease" was invented by Jeffrey Bender (Orange, Conn.), Vinod Ramgolam (New Haven, Conn.) and Timur Yarovinsky (Woodbridge, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In various aspects and embodiments the invention provides compositions and methods useful in the treatment of inflammatory disease, in particular, multiple sclerosis."

The patent was filed on June 6, 2023, under Application No. 18/330,357.

*For further information, including im...